APA (7th ed.) Citation

J, W., L, G., G, Z., Y, W., KJ, T., J, X., & J, C. (2025). Simultaneous Determination of Osimertinib and its Metabolites in Human Plasma for Clinical Applications Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Therapeutic drug monitoring, 47(6), 747. https://doi.org/10.1097/FTD.0000000000001355

Chicago Style (17th ed.) Citation

J, Wu, Guo L, Zhou G, Wang Y, Tang KJ, Xu J, and Chen J. "Simultaneous Determination of Osimertinib and Its Metabolites in Human Plasma for Clinical Applications Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry." Therapeutic Drug Monitoring 47, no. 6 (2025): 747. https://doi.org/10.1097/FTD.0000000000001355.

MLA (9th ed.) Citation

J, Wu, et al. "Simultaneous Determination of Osimertinib and Its Metabolites in Human Plasma for Clinical Applications Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry." Therapeutic Drug Monitoring, vol. 47, no. 6, 2025, p. 747, https://doi.org/10.1097/FTD.0000000000001355.